HEALTH Gene Research

  NEWS
  Politics
  Nation
  World
  Metro
  Style
  Business
  Technology
    HEALTH
    Alternative Care
    Children & Youth
    Chronic Diseases
    Fitness
    Health Care Issues
    Men
    Mental Health
    Nutrition
    Seniors
    Women
    Columns
    Special Reports
     Gene Research
   - Gelsinger Case
    Live Discussions
    Photo Galleries
    Health Index
  Education
  Real Estate
  Obituaries
  Corrections
  Archives

washingtonpost.com > Health > Special Reports > Gene Research


Announcement


This section will no longer be updated. For the latest news, go to the new Health Section or the washingtonpost.com home page.



Gelsinger Case
Jesse Gelsinger Gene Therapy Death: Jesse Gelsinger, 18, died in September 1999 after a failed experimental therapy administered by the University of Pennsylvania (full report).
Graphic
graphic Library of Life:
Interactive graphic shows the makeup of human genes.(Flash Required)

Background
The Human Genome Project formally began in October 1990 with the goals of identifying the more than 100,000 genes in human DNA, determining the sequences of the 3 billion chemical base pairs in DNA, and storing this information in databases for future analysis and application.

The National Institutes of Health's Human Genome Research Institute and the Department of Energy's Human Genome Program together make up the U.S. Human Genome Project. The U.K.'s Wellcome Trust, a private philanthropy, also contributes to the global initiative.

Q & A on the Human Genome
Biotechnology Special Report
Pharmaceuticals Special Report
Cloning Special Report

Web Resources
Web Links Human Genome Project Information
 GeneMed Network
 National Human Genome Research Project
 American Society of Gene Therapy
 Pharmaceutical Research and Manufacturers of America
 National Bioethics Advisory Committee
 The Center for Bioethics and Human Dignity
Cancer Prompts FDA to Halt Gene Therapy
The FDA has suspended U.S. gene therapy experiments after learning that a third child who underwent treatment in France has developed cancer as a result.

Related Stories
Harvard Team Seeks to Clone Embryos for Stem Cells (Post, Oct. 14, 2004)

How Genes Affect Moods (washingtonpost.com, Dec. 2, 2003; 1:32 PM)

U.N. Postpones Debate on Human Cloning: Action Derails Bid for a Vote on a U.S.-Backed Measure Calling for a Moratorium (Post, Nov. 7, 2003)

Scientists Produce Human Embryos of Mixed Gender (Post, July 3, 2003)

Stem Cell 'Master Gene' Found: Ability to Manipulate It May Aid Therapy (Post, May 30, 2003)

Genome Project Completed: Findings May Alter Humanity's Sense of Itself, Experts Predict (Post, April 15, 2003)

Bouncing Banteng Born To Iowa Cow: First Healthy Clone of An Endangered Species (Post, April 8, 2003)

Panel Urges Restricted Use of Gene Therapy (Post, March 1, 2003)

Dream Unmet 50 Years After DNA Milestone: Gene Therapy Debacle Casts Pall on Field (Post, Feb. 28, 2003)

Second Boy Receiving Gene Therapy Develops Cancer: FDA Responds to Event in France by Suspending 27 U.S. Studies Involving Similar Techniques (Post, Jan. 15, 2003)

High-Altitude Breathing May Be in One's Blood (Post, Dec. 23, 2002)

Bacterium Inside Fly Could Be Key to a Cure (Post, Nov. 25, 2002)

Scientists Planning to Make New Form of Life (Post, Nov. 22, 2002; 3:06 PM)

Gene-Therapy Tests Show Positive Results, GenVec Says (Post, Nov. 21, 2002)

Paternity Test Firm Problems Plague D.C. (Post, Nov. 18, 2002)

Loss Widens at Gaithersburg Gene-Drug Firm GenVec (Post, Nov. 1, 2002)

Global Project on Genetic Variation Begins: Scientists Hope Effort Leads to Better Understanding of Common Diseases' Hereditary Basis (Post, Oct. 30, 2002)

Resumption of Gene Therapy Urged: Advisory Panel Backs Restrictions After Treatment Triggered French Boy's Illness (Post, Oct. 11, 2002)

Gene Therapy Apparently Leads to New Illness in Boy: Health Officials in U.S., France Suspend Treatments Recently Hailed as Cure for Immune Disorder (Post, Oct. 4, 2002)

More Stories


© 2002-2005 The Washington Post Company

health_vm women's health care